1.  **What do we already know about this topic?**

2.  Cancer patients have higher health care expenditures than those without cancer.

3.  **How does your research contribute to the field?**

4.  We note 3 key contributions to the existing literature on the health care expenditure burden of cancer care in the United States. First, we provide national estimates of cancer care costs at the individual level, which could be useful resources for the development of insurance design and policies to address the rising costs of cancer care. In addition, our age group comparisons allowed us to demonstrate that young cancer patients had a relatively high financial burden of cancer care compared with both those without cancer and elderly patients with cancer. Last, we particularly provide and compare the estimates of cancer care for the 4 most common cancers, breast, lung, prostate, and colorectal cancer, which were not well addressed in previous studies.

5.  **What are your research's implications toward theory, practice, or policy?**

6.  By providing the estimates of expenditures by source of payment and type of service, our findings would be useful resources for policy makers, health care system, and employers when they design benefits for cancer patients or develop policies to address the rising costs of cancer care.

Introduction {#section1-0046958019880696}
============

Cancer research over the past few decades has led to advances in the early detection and treatment of cancer, resulting in declines in overall incidence and death rates due to cancer.^[@bibr1-0046958019880696]^ However, cancer remains the second leading cause of death in the United States and cancer survivors are a rapidly growing population, and is expected to rise to 19 million by 2024 due to the growth and aging of the US population.^[@bibr2-0046958019880696][@bibr3-0046958019880696][@bibr4-0046958019880696]-[@bibr5-0046958019880696]^ The most commonly diagnosed cancer in the United States is breast cancer, with more than 255 000 new cases expected among men and women in 2017.^[@bibr6-0046958019880696]^ The next most common cancers are lung, prostate, and colorectal cancers, excluding nonmelanoma skin cancers.^[@bibr7-0046958019880696]^

Health care expenditures on cancer treatment have also greatly increased over the past 2 decades. According to the Agency for Healthcare Research and Quality, a total of \$57 billion was spent on cancer care in 2001, compared with \$88.3 billion in 2011,^[@bibr8-0046958019880696]^ and the National Cancer Institute reported that national estimates of cancer care costs are expected to rise to as high as \$173 billion by 2020.^[@bibr2-0046958019880696]^ These increasing costs pose financial challenges for patients, families, governments, and society as a whole.^[@bibr9-0046958019880696]^ For example, the financial burden of cancer care has been linked to several negative consequences for patients, such as medical debts, bankruptcies, forgoing or delaying necessary medical care, or avoiding filling prescriptions.^[@bibr9-0046958019880696]^ In addition, poor adherence to cancer treatment can have drastic consequences for cancer patients, resulting in less effective treatment, shorter survival, poorer prognosis, and greater risk of recurrence.^[@bibr9-0046958019880696],[@bibr10-0046958019880696]^ From the societal standpoint, these consequences may lead to lost worker productivity and additional health care spending.^[@bibr11-0046958019880696]^ Thus, estimating the nature and extent of health care spending on cancer care is necessary to understand the scope of cancer costs and to inform the development of policies and programs to address the rising costs of cancer care, which is an increasingly important issue for health care policy makers, health care systems, employers, and society.^[@bibr12-0046958019880696]^

Although previous studies have estimated the costs of cancer care, estimated expenditures vary widely by study depending on the scope of the analysis, study population, data, and study period.^[@bibr2-0046958019880696],[@bibr13-0046958019880696][@bibr14-0046958019880696][@bibr15-0046958019880696][@bibr16-0046958019880696][@bibr17-0046958019880696]-[@bibr18-0046958019880696]^ These studies have generated gross national estimates of health care expenditures instead of estimates at the individual level,^[@bibr2-0046958019880696],[@bibr16-0046958019880696]^ or only include patients with specific cancer types^[@bibr13-0046958019880696],[@bibr15-0046958019880696]^ or used outdated data.^[@bibr14-0046958019880696],[@bibr17-0046958019880696],[@bibr18-0046958019880696]^ Although the gross national estimates of expenditures are important to estimate the overall economic burden of cancer care on the US health care system, the estimates of expenditures at the individual level are also crucial to understand the extent of financial burden of cancer care for individuals. In this regard, using nationwide data, this study builds on previous studies by estimating and comparing mean annual health care expenditures per person between patients with and without cancer, and among patients with breast, lung, prostate, and colorectal cancer. Expenditures were also examined by source of payment and by type of service.

Methods {#section2-0046958019880696}
=======

Data {#section3-0046958019880696}
----

Five years of data were pooled from the 2010 to 2014 waves of the Medical Expenditure Panel Survey (MEPS). The MEPS is a nationally representative panel survey sponsored by the Agency for Healthcare Research and Quality that provides comprehensive data on health care use, expenditures, sources of payment, and health insurance coverage in the US civilian noninstitutionalized population, as well as survey respondents' health status, medical conditions, and sociodemographic characteristics.^[@bibr19-0046958019880696]^ The MEPS collects expenditure information using a combination of self-reported responses in the MEPS household component and follow-back surveys with providers in the linked MEPS medical provider component.^[@bibr19-0046958019880696]^ From the MEPS household component, detailed information on health care expenditures, health insurance coverage, demographics, and socioeconomic characteristics were used.^[@bibr19-0046958019880696]^ The linked Medical Conditions files were utilized to identify the cancer patient population in this study.^[@bibr20-0046958019880696]^

Study Population {#section4-0046958019880696}
----------------

All adults aged 18 years or older were selected in each study year. Cancer patients were identified using the medical condition variable, CCCODEX, in the Medical Conditions file, which compiles the *International Classification of Disease, Ninth Revision, Clinical Modification* codes into clinically meaningfully categories.^[@bibr20-0046958019880696]^ The CCCODEX values from 11 to 45 were used to identify cancer patients who were currently experiencing any type of cancer.^[@bibr21-0046958019880696]^ The following code values were selected to identify patients with the 4 most common cancers: 24 for breast, 19 for lung, 29 for prostate, and 14 and 15 for colorectal cancer.

Health Care Expenditures {#section5-0046958019880696}
------------------------

The main outcome of interest was the mean of annual health care expenditures, which were estimated at the individual level. Health care expenditures were estimated using the sum of direct payments for all health care services during the year, by source of payment (private insurance, Medicare, Medicaid, out-of-pocket, and others), type of service (ambulatory care, hospital inpatient care, prescription medicines, and other services), and age group (18 to 64 and ≥65 years). Out-of-pocket expenditures included deductibles, co-insurance, and co-payments paid for all health care services, excluding over-the-counter drugs. Consistent with previous research, the sample for each source of payment included all individuals who had positive payments from that source.^[@bibr16-0046958019880696]^ Adjusted analyses of expenditures were conducted controlling for age, sex, race/ethnicity, marital status, education, poverty status, health insurance status, and number of chronic conditions. These covariates were selected based on the Andersen's Behavioral Model of Health Services Use (6th edition),^[@bibr22-0046958019880696]^ which was used as a guiding theoretical framework and helped to identify variables associated with utilization of and expenditures for health care services among cancer patients. Demographic variables such as age, sex, race/ethnicity, marital status, and education were used as predisposing factors because it was believed that these variables might affect use of health care services. Poverty status and health insurance status were included as enabling factors, which affect an individual's ability to obtain and pay for health care services. Last, the number of health conditions were considered as need factors because it may lead to need for health care services and health care expenditures. All expenditures were adjusted to 2014 US dollars using the Consumer Price Index.

Statistical Analysis {#section6-0046958019880696}
--------------------

Two-part models were used to estimate health care expenditures overall and for cancer care, accounting for zero expenditure values and skewness in the distribution of expenditures. For the first part of the model, logistic regression was used to predict the probability of whether or not an individual had a positive expenditure. In the second part of the model, a generalized linear regression model with a log link and gamma distribution was used to predict mean expenditures only for those who had positive expenditures.^[@bibr23-0046958019880696]^ The same covariates were included in both models, which were also stratified by age (18 to 64 and ≥ 65 years). Separate two-part models were estimated to predict mean expenditures for each group by payment source and service type. Expenditures were then compared between cancer and noncancer patients, as well as among patients with the 4 most common cancers. Statistical differences were evaluated for these comparisons using *t* tests and analysis of variance, respectively.

Descriptive statistics were used to describe the sample characteristics. Statistical differences for each comparison group were evaluated using chi-square tests for categorical variables and *t* tests for continuous variables. All statistical analyses were conducted at an alpha level of 0.05, and 95% confidence intervals were derived for expenditures using Stata 14.2 (StataCorp, College Station, Texas). All estimates were weighted to represent national estimates for the civilian noninstitutionalized US population and reported at the person level. Survey weights were adjusted for pooling to represent the average annual population size from 2010 to 2014.

Results {#section7-0046958019880696}
=======

Sample Characteristics {#section8-0046958019880696}
----------------------

Of 121 482 individuals aged ≥18 years, 6799 were cancer patients (weighted = 17 244 586). Of these, 3269 were nonelderly cancer patients aged 18 to 64 years (weighted = 7 869 226) and 3530 were elderly cancer patients ≥65 years (weighted = 9 375 340). The majority of cancer patients were female, non-Hispanic white, married, had some college degree, had high income, and had ≥2 chronic health conditions ([Online Appendix 1](https://journals.sagepub.com/doi/suppl/10.1177/0046958019880696)). Cancer patients were more likely to have public insurance and less likely to be uninsured compared with those without cancer. Among patients with the 4 most common cancers, patients with breast cancer were more likely to be younger, and those with prostate cancer were more likely to be 65 or older ([Online Appendix 2](https://journals.sagepub.com/doi/suppl/10.1177/0046958019880696)). Patients with lung and colorectal cancer had lower education and were more likely to be poor or low-income, have public insurance, and be uninsured compared with those with breast and prostate cancer. Lung cancer patients were more likely to have multiple chronic health conditions than the other cancer types.

Annual Health Care Expenditures {#section9-0046958019880696}
-------------------------------

### Cancer patients versus noncancer patients {#section10-0046958019880696}

Overall, cancer patients had significantly higher mean annual health care expenditures than those without cancer ([Table 1](#table1-0046958019880696){ref-type="table"}). Estimated mean expenditures for all adult cancer patients were \$16 346, which was nearly 4 times higher than those without cancer (\$4484). Cancer patients aged 18 to 64 years had mean expenditures of \$17 210, compared with \$3770 for those without cancer. Smaller differences were seen among those ≥65 years, where mean expenditures were \$14 368 for cancer patients and \$8634 for those without cancer.

###### 

Mean Annual Health Care Expenditures Between Noncancer and Cancer Patients, by Age Group, Source of Payment, and Service Type.

![](10.1177_0046958019880696-table1)

                                                                                                 No cancer   Any cancer   *P* ^[a](#table-fn2-0046958019880696){ref-type="table-fn"}^                   
  --------------------------------------------------------------------- ------------------------ ----------- ------------ ------------------------------------------------------------- --------------- --------
  All adults (≥ 18 years)                                               All sources of payment   \$4484      4361-4607    \$16 346                                                      15 141-17 552   \<.001
  Source of payment                                                                                                                                                                                     
   Private insurance                                                    \$2249                   2158-2339   \$5308       4718-5899                                                     \<.001          
   Medicare                                                             \$1248                   1179-1317   \$5959       5366-6553                                                     \<.001          
   Medicaid                                                             \$433                    388-478     \$686        525-848                                                       \<.01           
   Out-of-pocket                                                        \$682                    662-702     \$1596       1481-1712                                                     \<.001          
   Other                                                                \$422                    392-451     \$1395       1085-1705                                                     \<.001          
  Service type^[b](#table-fn3-0046958019880696){ref-type="table-fn"}^                                                                                                                                   
   Hospital inpatient service                                           \$1222                   1155-1290   \$4309       3725-4894                                                     \<.001          
   Ambulatory care visits                                               \$1698                   1637-1760   \$6476       6067-6884                                                     \<.001          
   Prescription medicines                                               \$1089                   1024-1153   \$3346       2961-3731                                                     \<.001          
   Other services                                                       \$730                    703-757     \$1565       1359-1772                                                     \<.001          
  Age 18-64 years                                                       All sources of payment   \$3770      3640-3900    \$17 210                                                      15 077-1 9343   \<.001
  Source of payment                                                                                                                                                                                     
   Private insurance                                                    \$2822                   2707-2938   \$12 619     10 769-14 469                                                 \<.001          
   Medicare                                                             \$389                    342-437     \$1889       1378-2401                                                     \<.001          
   Medicaid                                                             \$465                    415-516     \$1344       965-1723                                                      \<.001          
   Out-of-pocket                                                        \$592                    573-611     \$1507       1363-1652                                                     \<.001          
   Other                                                                \$371                    341-402     \$1688       989-2388                                                                      
  Service type^b^                                                                                                                                                                                       
   Hospital inpatient service                                           \$985                    915-1056    \$4609       3665-5552                                                     \<.001          
   Ambulatory care visits                                               \$1495                   1439-1550   \$6778       6075-7480                                                     \<.001          
   Prescription medicines                                               \$898                    828-969     \$3785       3010-4560                                                     \<.001          
   Other services                                                       \$601                    579-624     \$1254       974-1535                                                      \<.001          
  Age ≥ 65 years                                                        All sources of payment   \$8634      8303-8965    \$14 368                                                      13 337-15 398   \<.001
  Source of payment                                                                                                                                                                                     
   Private insurance                                                    \$1267                   1155-1379   \$2022       1785-2259                                                     \<.001          
   Medicare                                                             \$5241                   5002-5480   \$9184       8267-10 102                                                   \<.001          
   Medicaid                                                             \$305                    235-375     \$170        118-222                                                       \<.001          
   Out-of-pocket                                                        \$1198                   1127-1269   \$1599       1458-1741                                                     \<.001          
   Other                                                                \$676                    600-751     \$1239       1037-1441                                                                     
  Service type^b^                                                                                                                                                                                       
   Hospital inpatient service                                           \$2549                   2335-2764   \$4068       3403-4734                                                     \<.001          
   Ambulatory care visits                                               \$2849                   2635-3063   \$6086       5600-6572                                                     \<.001          
   Prescription medicines                                               \$2198                   2094-2301   \$2745       2556-2934                                                     \<.001          
   Other services                                                       \$1466                   1360-1572   \$1767       1549-1984                                                     \<.01           

*Note.* All monetary amounts are in 2014 US dollars and rounded off to the nearest whole number. CI = confidence interval.

*P* values reflect 2-sample *t* test or chi-square test for differences from those without a history of cancer (No cancer group).

Ambulatory care visits included office-based visits and hospital outpatient visits. Hospital inpatient care referred to inpatient hospital stays including zero-night stays. Prescription medications included all medications for treatment of any conditions. Other services included emergency room visits, dental visits, home health care, vision aids and other medical supplies and equipment.

The differences in expenditures between cancer and noncancer patients varied by payment source and service type. Among all adult cancer patients, Medicare had the highest mean expenditures, although there were no major differences from private insurance, which was second highest. Conversely, private insurance had the highest mean expenditures for cancer patients aged 18 to 64 years, while Medicare was the highest among those ≥65 years. Higher mean annual out-of-pocket expenditures were seen among patients with cancer than those without cancer regardless of age group (\$1592 vs \$682), although these differences were smaller in the elderly group than in the nonelderly group (\$1599 vs \$1198 and \$1507 vs \$592, respectively). Mean annual expenditures by type of service for cancer and noncancer patients are shown in [Table 1](#table1-0046958019880696){ref-type="table"} and [Figure 1](#fig1-0046958019880696){ref-type="fig"}. Among cancer patients, ambulatory care visits accounted for the largest portion of health care expenditures regardless of age group (41%), followed by hospital inpatient (27%), prescription medicines (21%), and other services (10%).

![Percentage of health care expenditures by type of service between noncancer and cancer patients by age group.\
*Note.* Percentages are from predicted mean expenditures from two-part models controlling for age, sex, race/ethnicity, marital status, education, poverty status, health insurance status, and number of chronic conditions. Ambulatory care visits included office-based visits and hospital outpatient visits. Hospital inpatient care referred to inpatient hospital stays including zero-night stays. Prescription medications included all medications for treatment of any conditions. Other services included emergency room visits, dental visits, home health care, vision aids, and other medical supplies and equipment.](10.1177_0046958019880696-fig1){#fig1-0046958019880696}

Unweighted mean expenditures are available in [Online Appendix 3](https://journals.sagepub.com/doi/suppl/10.1177/0046958019880696) and full results of two-part models for all adults aged 18 years or older are presented in [Online Appendices 4 and 6](https://journals.sagepub.com/doi/suppl/10.1177/0046958019880696).

### Four most common cancers {#section11-0046958019880696}

Of the 4 most common cancer types, mean expenditures were the highest among lung cancer patients followed by colorectal cancer patients, across all age groups ([Table 2](#table2-0046958019880696){ref-type="table"}). Among lung cancer patients, mean expenditures were \$35 141 for all adult cancer patients, \$38 247 for those aged 18 to 64 years, and \$33 752 for those ≥65 years. Expenditures among breast cancer and prostate cancer patients were less than half of those seen in lung cancer patients.

###### 

Mean Annual Health Care Expenditures Among Patients With Four Most Common Cancers, by Age Group, Source of Payment, and Service Type.

![](10.1177_0046958019880696-table2)

                                                                                                 Breast cancer   Lung cancer      Prostate cancer   Colorectal cancer   *P* ^[a](#table-fn5-0046958019880696){ref-type="table-fn"}^                                                 
  --------------------------------------------------------------------- ------------------------ --------------- ---------------- ----------------- ------------------- ------------------------------------------------------------- --------------- ------------- --------------- -------
  All adults (≥ 18 years)                                               All sources of payment   \$14 912        12 955, 16 870   \$35 141          27 123-43 158       \$15 613                                                      12 061-19 165   \$23 294      17 404-29 185   \<.01
  Source of payment                                                                                                                                                                                                                                                                 
   Private insurance                                                    \$8582                   6774-10 391     \$21 018         12 519-29 518     \$5389              3270-7507                                                     \$14 058        7845-20 271   \<.01           
   Medicare                                                             \$4731                   3741-5720       \$18 948         11 390-26 507     \$7982              5680-10 284                                                   \$9219          6351-12 088   \<.01           
   Medicaid                                                             \$1059                   653-1466        \$1053           364-1743          \$316               133-499                                                       \$1560          552-2568      \<.01           
   Out-of-pocket                                                        \$1616                   1337-1894       \$1421           1134-1709         \$1329              1164-1494                                                     \$1434          1158-1710     0.28            
   Other                                                                \$1113                   669-1558        \$4082           1092-7072         \$1714              1206-2221                                                     \$1810          403-3217      \<.05           
  Service type^[b](#table-fn6-0046958019880696){ref-type="table-fn"}^                                                                                                                                                                                                               
   Hospital inpatient service                                           \$2620                   1801-3439       \$12 179         7239-17 119       \$5488              3074-7902                                                     \$9220          5450-12 990   \<.01           
   Ambulatory care visits                                               \$7814                   6492-9135       \$15 099         10 266-19 932     \$6081              5220-6943                                                     \$9068          7154-10 982   \<.01           
   Prescription medicines                                               \$3410                   2847-3974       \$4165           2968-5363         \$2247              1913-2582                                                     \$2941          2188-3695     \<.01           
   Other services                                                       \$1443                   1146-1740       \$2173           1309-3037         \$1689              1306-2073                                                     \$1633          986-2280      0.31            
  Age 18-64 years                                                       All sources of payment   \$16 046        13249-18 843     \$38 247          25745-50 750        \$14 832                                                      8769-20 896     \$28 021      14994-41 048    \<.01
  Source of payment                                                                                                                                                                                                                                                                 
   Private insurance                                                    \$12 168                 9218-15 118     \$35 600         16 005-55 195     \$12 692            5705-19 679                                                   \$25 938        8550-43 326   0.10            
   Medicare                                                             \$2332                   870-3794        \$4753           787-8718          \$407               74-739                                                        \$2918          561-5276      \<.01           
   Medicaid                                                             \$1952                   1113-2791       \$3000           227-5773          \$843               90-1597                                                       \$3190          1067-5312     0.07            
   Out-of-pocket                                                        \$1520                   1294-1746       \$1613           1140-2086         \$1197              891-1503                                                      \$1843          1176-2509     0.19            
   Other                                                                \$1113                   669-1558        \$4082           1092-7072         \$1714              1206-2221                                                     \$1810          403-3217      0.54            
  Service type^[b](#table-fn6-0046958019880696){ref-type="table-fn"}^                                                                                                                                                                                                               
   Hospital inpatient service                                           \$2213                   1426-3000       \$15 977         6751-25 202       \$6839              602-13 075                                                    \$12 371        3896-20 845   \<.01           
   Ambulatory care visits                                               \$9500                   7314-11 685     \$15 493         9374-21 611       \$6295              4257-8333                                                     \$12 779        7471-18 088   \<.01           
   Prescription medicines                                               \$4067                   2796-5339       \$3161           1641-4680         \$1543              1006-2080                                                     \$3070          1750-4389     \<.01           
   Other services                                                       \$1070                   863-1277        \$2113           983-3243          \$1170              690-1651                                                      \$1194          429-1958      0.35            
  Age ≥ 65 years                                                        All sources of payment   \$13 820        11 705-15 935    \$33 752          22693-44 811        \$15 529                                                      11 750-19 307   \$19 053      13 914-24 193   \<.01
  Source of payment                                                                                                                                                                                                                                                                 
   Private insurance                                                    \$2480                   1873-3087       \$3378           1045-5710         \$1671              1229-2114                                                     \$2595          1260-3929     \<.05           
   Medicare                                                             \$7748                   6054-9441       \$25 907         15 045-36 769     \$10 403            7412-13 395                                                   \$13 013        8905-17 121   \<.01           
   Medicaid                                                             \$420                    143-696         \$430            86-773            \$148               54-243                                                        \$326           25-627        0.09            
   Out-of-pocket                                                        \$1690                   1227-2154       \$1354           1003-1704         \$1365              1173-1558                                                     \$1308          971-1645      0.49            
   Other                                                                \$779                    497-1062        \$2862           1190-4533         \$1605              1069-2140                                                     \$830           483-1176                      
  Service type^[b](#table-fn6-0046958019880696){ref-type="table-fn"}^                                                                                                                                                                                                               
   Hospital inpatient service                                           \$3093                   1614-4572       \$9014           5243-12 784       \$4890              2748-7031                                                     \$8564          3929-13 199   \<.05           
   Ambulatory care visits                                               \$6379                   5188-7571       \$14 319         8358-20 281       \$5827              4968-6685                                                     \$6420          3999-8840     \<.05           
   Prescription medicines                                               \$2968                   2501-3435       \$4471           2941-6001         \$2441              2011-2872                                                     \$2953          1949-3957     .07             
   Other services                                                       \$1810                   1291-2330       \$1848           1033-2663         \$1863              1385-2341                                                     \$1990          1102-2878     .98             

*Note.* All monetary amounts are in 2014 US dollars and rounded off to the nearest whole number. CI = confidence interval; ANOVA = analysis of variance.

P values reflect ANOVA test for differences among the 4 types of cancer groups: breast, lung, prostate, and colorectal cancer.

Ambulatory care visits included office-based visits and hospital outpatient visits. Hospital inpatient care referred to inpatient hospital stays including zero-night stays. Prescription medications included all medications for treatment of any conditions. Other services included emergency room visits, dental visits, home health care, vision aids and other medical supplies and equipment.

Among all adult cancer patients with the 4 most common cancers, private health insurance had the highest mean expenditures for breast, lung, and colorectal cancer, whereas Medicare had the highest for prostate cancer. Private health insurance had the highest mean expenditures for patients aged 18 to 64 years, and Medicare had the highest for those ≥65 years. Despite markedly different total expenditures, there were no significant differences in mean annual out-of-pocket expenditures across the cancer types.

Among breast cancer patients, ambulatory care visits accounted for the largest proportion of spending, regardless of age group ([Figure 2](#fig2-0046958019880696){ref-type="fig"}). Among patients with lung, prostate, and colorectal cancer aged 18 to 64 years, hospital inpatient and ambulatory care visits accounted for the largest share of expenditures. Among those ≥65 years, ambulatory care visits accounted for the largest share of expenditures among patients with lung and prostate cancer, while hospital inpatient care accounted for the largest share among colorectal cancer patients. Full results for all adults aged 18 years or older are available in Online [Appendices 5 and 7](https://journals.sagepub.com/doi/suppl/10.1177/0046958019880696).

![Percentage of health care expenditures by type of service among patients with the 4 most common cancers by age group: Medical Expenditure Panel Survey, 2010 to 2014.\
*Note.* Ambulatory care visits included office-based visits and hospital outpatient visits. Hospital inpatient care referred to inpatient hospital stays including zero-night stays. Prescription medications included all medications for treatment of any conditions. Other services included emergency room visits, dental visits, home health care, vision aids, and other medical supplies and equipment.](10.1177_0046958019880696-fig2){#fig2-0046958019880696}

Discussion {#section12-0046958019880696}
==========

Cancer treatment exerts a considerable economic burden on the US health care system. Compared with individuals without cancer, mean annual health care expenditures per person were nearly 4 times higher among cancer patients (\$16 346 vs \$4484), with greater differences seen among those age 18 to 64 years than those ≥65 years. These expenditures were substantially higher than those seen in the general US population, which were \$8054 in 2014.^[@bibr24-0046958019880696]^ The trends seen in this study were similar to a previous study using data from 2008 to 2010, although the magnitude of expenditures for cancer patients were higher, reflecting the rising costs of cancer treatment.^[@bibr18-0046958019880696]^ As spending on ambulatory care visits accounted for the majority of health care expenditures for both cancer and noncancer patients, ambulatory care visits could be a prime target for cost-containment strategies. In addition, the distribution of expenditures by type of service varied by cancer type, which implies that multiple strategies may be needed to address treatment costs for different cancer types.

We note 3 key contributions to the existing literature on the health care expenditure burden of cancer care in the United States. First, we provide national estimates of cancer care costs at the individual level, which could be useful resources for the development of insurance design and policies to address the rising costs of cancer care. In addition, our age group comparisons allowed us to demonstrate that young cancer patients had a relatively high financial burden of cancer care compared with both those without cancer and elderly patients with cancer. Last, we particularly provide and compare the estimates of cancer care for the 4 most common cancers, breast, lung, prostate, and colorectal cancer, which were not well addressed in previous studies.^[@bibr2-0046958019880696],[@bibr13-0046958019880696][@bibr14-0046958019880696][@bibr15-0046958019880696][@bibr16-0046958019880696][@bibr17-0046958019880696]-[@bibr18-0046958019880696]^

This study found that younger cancer patients had relatively higher health care costs burden than elderly cancer patients. Cancer patients age 18 to 64 years had higher mean expenditures than elderly patients age ≥65 years (\$17 210 vs \$14 348) and the differences in mean expenditures between noncancer and cancer patients were considerably higher among younger cancer patients than among elderly patients; the difference was 4 times more among younger cancer patients, while nearly twice as high among elderly cancer patients. These findings imply that younger patients with cancer may face considerably more financial hardship than elderly patients. Furthermore, considering that patients age 18 to 64 years are the working-age population, they may bear additional indirect costs due to cancer, such as lost productivity due to employment disability, missed workdays, or lost household productivity.^[@bibr18-0046958019880696],[@bibr25-0046958019880696]^ As there are still a considerable number of people who are underinsured (45%) or uninsured (12%) among the working-age population in the United States,^[@bibr26-0046958019880696],[@bibr27-0046958019880696]^ this group may be more vulnerable to the financial burden of cancer care, and should be carefully considered by employers and policy makers when designing insurance benefits.

Among patients with the 4 most common cancers, overall, patients with lung cancer were more likely to have significantly higher mean annual health care expenditures followed by patients with colorectal cancer, which is consistent with previous research.^[@bibr17-0046958019880696]^ This may reflect the differences in stage distribution at diagnosis, survival, intensity of treatment, and comorbidity burden for patients with lung cancer. Previous research has shown that the costs of cancer care are highest in the initial and last year of life, representing a nonlinear U-shaped curve.^[@bibr17-0046958019880696]^ For lung cancer, most patients are diagnosed at advanced stages with relatively short survival duration, with a 5-year survival rate of 18.6% for lung cancer compared with 89.7% for breast cancer, 98.2% for prostate cancer, and 64.5% for colorectal cancer; thus, more intensive care may be necessary for patients with lung cancer, leading to higher spending on both hospital inpatient and outpatient services.^[@bibr3-0046958019880696],[@bibr4-0046958019880696],[@bibr17-0046958019880696]^ In addition, patients with lung cancer have a higher comorbidity burden than other cancer types, which is supported by our findings and previous research.^[@bibr3-0046958019880696]^ Colorectal cancer patients had the second highest mean expenditures with higher spending on hospital inpatient services, which may be due to the nature of treatment for colorectal cancer where surgery is the most common treatment for all stages of colon cancer.^[@bibr28-0046958019880696]^ The survival rate is relatively lower than for breast and prostate cancer, although it is higher than lung cancer.^[@bibr4-0046958019880696]^

Due to higher out-of-pocket expenditures, cancer patients are exposed to higher economic burdens than those without cancer. Although out-of-pocket expenditures were similar across the 4 most common cancers, the extent of financial burden patients experience will vary based on their income and financial resources available, which may vary by cancer type. For example, patients with lung and colorectal cancer may be more likely to experience higher financial burden than others because they were more likely to be poor or low-income and/or older. As financial burden due to cancer care has been linked to adverse health consequences including forgoing or delaying necessary medical care and poor medication adherence,^[@bibr9-0046958019880696]^ comprehensive cost-saving strategies are needed to protect patients from the high and rising costs of cancer care.

When comparing expenditures by source of payment, important differences were observed where private insurance was the largest payment source for cancer patients age 18 to 64, whereas Medicare was the largest for those ≥65 years. For example, Medicare paid approximately 3 times as much for elderly breast cancer patients as private insurance and 10 times as much for prostate cancer. The increasing share of cancer treatments paid by Medicare will continue to rise as it is expected that 73% of cancer survivors will be ≥65 years by 2040.^[@bibr3-0046958019880696]^ The significantly greater burden of cancer treatment costs on publicly funded program such as Medicare is an important policy issue, as the responsibility of paying for cancer treatment will be increasingly passed on to taxpayers, government, and society, alongside the increasing financial burden on cancer patients. Policy makers and health plan administrators should utilize these findings when considering cost-saving strategies, and cost-effective cancer treatment should be emphasized by providers and health systems. This study is subject to several limitations. The MEPS data only include noninstitutionalized patients as a survey sample, which may result in an underestimation of cancer patients with particular types or severity of cancer, which would result in underestimates of cancer expenditures. Second, it was not possible to estimate expenditures by cancer stage or intensity due to a lack of information in the data, which might also contribute to higher expenditures. Third, all-cause health care expenditures were estimated as information on cancer-attributable expenditures were not available. Last, although our findings may include some early effects of policy changes under the Affordable Care Act (ACA), future research might be needed to specifically examine the impact of the ACA on health care expenditure burden of cancer care by providing trends in expenditures before and after the ACA.

Conclusions {#section13-0046958019880696}
===========

As the costs of cancer care are expected to continue increasing in the near future, comprehensive policies and programs are needed to reduce the costs of cancer care while maintaining or improving important aspects of oncology care such as access to high-value interventions, evidence-based use of treatment, and patient-centered care.^[@bibr29-0046958019880696]^ Estimated mean annual health care expenditures for cancer patients are nearly 4 times higher than for those without cancer, with lung cancer patients having the highest mean expenditures among the 4 most common cancers. Medicare pays a significant amount of health care costs for cancer patients. The findings in this study may be helpful in developing comprehensive cost-saving strategies for cancer care in the United States.
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